Figure 5.

Influence of cOVA administration on NK1.1⁺ thymocytes in (B6 × DO10)F₁ and (D2 × DO10)F₁ mice. Thymocytes from cOVA- or PBS-treated mice were isolated and stained with PE-anti-NK1.1, FITC-anti-CD4, and biotin-KJ1-26 or biotin-anti-Vβ8 followed by Streptavidin-FITC. A representative profile from three separate experiments is shown. The proportions of NK1.1⁺, NK1.1⁺ CD4⁻, and NK1.1⁺ CD4⁺ cells (Left), NK1.1⁺KJ1-26⁺ (NK1.1⁺KJ1-26^low and NK1.1⁺KJ1-26^intermediate) (Middle), and NK1.1⁺Vβ8⁺ (Right) cells are indicated.